AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. SymBio Pharmaceuticals Limited
  3. Financials
  4. Operating expenses

SymBio Pharmaceuticals Limited【JP:4582】

Market cap
¥6.3B
P/E ratio
-1.8x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndOperating expenses (Million JPY)YoY (%)
Dec 31, 20255,388-6.30%
Dec 31, 20245,750+10.10%
Dec 31, 20235,223-7.34%
Dec 31, 20225,636+17.81%
Dec 31, 20214,784-10.96%
Dec 31, 20205,373+4.00%
Dec 31, 20195,166+34.93%
Dec 31, 20183,829-23.09%
Dec 31, 20174,978+64.23%
Dec 31, 20163,031-3.30%
Dec 31, 20153,135+71.30%
Dec 31, 20141,830

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)